EssilorLuxottica to purchase AI-focused ophthalmology platform Optegra
Investing.com -- EssilorLuxottica, the Franco-Italian eyewear group and maker of Ray-Ban, announced its plans to acquire Optegra, an AI-focused ophthalmology platform, from MidEuropa. This move is part of the company’s strategy to expand its medical technology portfolio.
On Friday, the eyewear group stated that this acquisition will enhance its current offerings, which already extend beyond frames and lenses. The company also provides AI-powered technologies, wearables, medical instruments, and scientifically proven eyecare solutions.
In the previous year, EssilorLuxottica had expanded its partnership with Meta, Facebook (NASDAQ:META)’s parent company, to create smart Ray-Ban glasses. This collaboration was part of the company’s ongoing efforts to incorporate artificial intelligence into its operations.
Optegra operates more than 70 eye hospitals and diagnostic facilities in the U.K., Czech Republic, Poland, Slovakia, and the Netherlands. The platform offers ophthalmic treatments and elective vision correction procedures, which are supported by artificial intelligence during the pre- and postoperative stages.
The financial details of the transaction have not been disclosed. The completion of the acquisition is expected later this year, pending approval.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
